Published in Endocrinology on March 01, 2000
Vascular endothelial growth factors and vascular permeability. Cardiovasc Res (2010) 1.89
Patterns of gene expression in the bovine corpus luteum following repeated intrauterine infusions of low doses of prostaglandin F2alpha. Biol Reprod (2012) 1.46
Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol (2003) 1.37
Angiogenesis in the corpus luteum. Reprod Biol Endocrinol (2003) 1.20
Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ Res (2005) 1.20
Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology (2009) 1.17
PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling. Mol Cell Biol (2010) 1.14
Angiogenesis in the female reproductive organs: pathological implications. Int J Exp Pathol (2002) 1.13
The anti-angiogenic isoforms of VEGF in health and disease. Biochem Soc Trans (2009) 1.07
VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer. J Cancer Res Clin Oncol (2011) 0.87
On aerobic exercise and behavioral and neural plasticity. Brain Sci (2012) 0.86
Inhibition of delta-like ligand 4 induces luteal hypervascularization followed by functional and structural luteolysis in the primate ovary. Endocrinology (2012) 0.84
Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertility. Reproduction (2012) 0.83
Luteal blood flow and luteal function. J Ovarian Res (2009) 0.79
Luteal blood flow in patients undergoing GnRH agonist long protocol. J Ovarian Res (2011) 0.76
Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterus. Am J Physiol Heart Circ Physiol (2014) 0.76
Developmental Programming: Does Prenatal Steroid Excess Disrupt the Ovarian VEGF System in Sheep? Biol Reprod (2015) 0.75
Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal Permeability. Geburtshilfe Frauenheilkd (2017) 0.75
Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth. Oncogenesis (2017) 0.75
Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest (1997) 3.39
The production and molecular properties of the zinc beta-lactamase of Pseudomonas maltophilia IID 1275. Biochem J (1985) 2.48
Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation (2001) 2.46
Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst (1995) 2.07
Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res (2001) 1.97
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res (2000) 1.88
Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res (1994) 1.72
An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res (1997) 1.63
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res (1993) 1.58
The pH-dependence of class B and class C beta-lactamases. Biochem J (1983) 1.58
Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci U S A (1995) 1.54
Cryoenzymology of Bacillus cereus beta-lactamase II. Biochemistry (1985) 1.50
Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms. Nat Neurosci (2000) 1.49
Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol (1992) 1.48
Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry (1992) 1.47
Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytes. Blood (1999) 1.45
Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol (1995) 1.45
In silico cloning of novel endothelial-specific genes. Genome Res (2000) 1.42
Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res (1995) 1.39
Post-partum changes in hormones and sexual behaviour in captive groups of marmosets (Callithrix jacchus). Physiol Behav (1987) 1.35
Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res (1992) 1.34
The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer (1996) 1.33
The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer (2000) 1.33
Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J (1998) 1.32
The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res (1996) 1.31
The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res (1997) 1.31
Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol (1999) 1.30
Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer (1995) 1.30
Adrenomedullin and tumour angiogenesis. Br J Cancer (2006) 1.27
Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res (1997) 1.24
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res (2000) 1.22
Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J Pathol (1998) 1.17
The isolation and long-term culture of normal human endometrial epithelium and stroma. Expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges. J Cell Sci (1995) 1.17
Germ cell differentiation in the marmoset (Callithrix jacchus) during fetal and neonatal life closely parallels that in the human. Hum Reprod (2008) 1.16
Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. Br J Cancer (1998) 1.16
Changes in the coordination geometry of the active-site metal during catalysis of benzylpenicillin hydrolysis by Bacillus cereus beta-lactamase II. Biochemistry (1986) 1.15
Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol (1998) 1.15
PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene (1998) 1.14
Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Br J Cancer (1997) 1.13
Single-turnover and steady-state kinetics of hydrolysis of cephalosporins by beta-lactamase I from Bacillus cereus. Biochem J (1985) 1.13
Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst (1994) 1.13
Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. Oncogene (2011) 1.11
Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression. Br J Cancer (2000) 1.10
Interleukin-4 is a potent mitogen for capillary endothelium. Biochem Biophys Res Commun (1991) 1.10
Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem (1993) 1.09
Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest (1993) 1.08
Angiogenesis in psoriasis. Angiogenesis (2002) 1.08
Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene (2001) 1.07
Clinical and endocrinological studies with the isomeric components of clomiphene citrate. J Obstet Gynaecol Br Commonw (1969) 1.05
Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. Gynecol Oncol (2008) 1.05
Modulation of mitogenic stimuli by angiogenin correlates with in vitro phosphatidylinositol bisphosphate synthesis. Proc Natl Acad Sci U S A (1989) 1.05
Trypanosomes in a declining species of threatened Australian marsupial, the brush-tailed bettong Bettongia penicillata (Marsupialia: Potoroidae). Parasitology (2008) 1.04
Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis. J Pathol (2000) 1.04
The promise of anti-angiogenic cancer therapy. Br J Cancer (2000) 1.03
Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res (1996) 1.01
Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells. Reproduction (2008) 1.01
Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. Trends Pharmacol Sci (1991) 1.01
Tumor stroma as a target in cancer. Curr Cancer Drug Targets (2008) 1.01
Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci (1995) 1.00
Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer. BJU Int (2000) 0.98
Regulation of Wnt5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor. J Biol Chem (1995) 0.98
Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: role of the mTORC1/2 and hypoxia-inducible factor pathways. Cell Death Dis (2013) 0.96
Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer (1998) 0.96
Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers. Gene Ther (2000) 0.96
Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. Mol Hum Reprod (2000) 0.94
Antibody for detecting p53 protein by immunohistochemistry in normal tissues. J Clin Pathol (1994) 0.94
Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod (2001) 0.94
Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer. Cancer (1994) 0.94
The isolation and culture of microvascular endothelium. J Cell Sci (1993) 0.94
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. Clin Cancer Res (2001) 0.93
Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral delivery. Hum Gene Ther (1997) 0.93
Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). J Clin Endocrinol Metab (2001) 0.92
Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion. Br J Cancer (2001) 0.91
New molecular pathways in angiogenesis. Br J Cancer (2003) 0.91
Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus. Mol Hum Reprod (2001) 0.91
Responses of pertussis toxin-treated microvascular endothelial cells to transforming growth factor beta 1. No evidence for pertussis-sensitive G-protein involvement in TGF-beta signal transduction. J Biol Chem (1992) 0.90
Angiogenesis and its control in the female reproductive system. Br Med Bull (2000) 0.90
In-vivo angiogenesis and progestogens. Hum Reprod (2002) 0.89
Regulation and manipulation of angiogenesis in the primate corpus luteum. Reproduction (2001) 0.88
Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. Br J Cancer (2003) 0.88
Failure of lactation to have a consistent effect on interbirth interval in the common marmoset, Callithrix jacchus jacchus. Folia Primatol (Basel) (1982) 0.88
Thymidine phosphorylase expression in endometrial carcinomas. Clin Exp Metastasis (1999) 0.88
Angiogenesis in the primate ovary. Reprod Fertil Dev (2001) 0.88
Role of the neonatal period of pituitary-testicular activity in germ cell proliferation and differentiation in the primate testis. Hum Reprod (2003) 0.88
Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology (1997) 0.87
Inhibition of ovarian function in subordinate female marmoset monkeys (Callithrix jacchus jacchus). J Reprod Fertil (1981) 0.87
Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin Cancer Res (2000) 0.87
Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis. BJU Int (2000) 0.87
Testicular changes during infantile 'quiescence' in the marmoset and their gonadotrophin dependence: a model for investigating susceptibility of the prepubertal human testis to cancer therapy? Hum Reprod (2002) 0.86
Changes in insulin-like growth factor-binding protein-3 messenger ribonucleic acid in endothelial cells of the human corpus luteum: a possible role in luteal development and rescue. J Clin Endocrinol Metab (2000) 0.86
The dormant in vivo phenotype of early stage primary human melanoma: termination by overexpression of vascular endothelial growth factor. Angiogenesis (1998) 0.86
Isolation and properties in culture of human adrenal capillary endothelial cells. Biochem Biophys Res Commun (1991) 0.85
Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor. J Endocrinol (2001) 0.85
Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas. Int J Oncol (2000) 0.85
The diversity, distribution and host-parasite associations of trypanosomes in Western Australian wildlife. Parasitology (2009) 0.85
Luteal regression in the primate: different forms of cell death during naturaland gonadotropin-releasing hormone antagonist or prostaglandin analogue-induced luteolysis. Biol Reprod (1999) 0.84
Transcriptional profiling of human microvascular endothelial cells in the proliferative and quiescent state using cDNA arrays. Angiogenesis (1999) 0.84